S3 Ep89: Social Media and Rare Cancers: Stay Informed, But Tread With Caution

S3 Ep89: Social Media and Rare Cancers: Stay Informed, But Tread With Caution

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs).
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it.
Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(297)

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb to launch "Investigating Myeloma," a disease awareness campaign honoring the 20th anniversary of her father Mickey Hargitay'...

8 Sep 6min

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

In our season 8 premiere, actor and longtime breast cancer advocate Rob Lowe joins CURE Talks Cancer to share his grandmother's breast cancer journey, including the clinical trial that helped prolong ...

31 Aug 14min

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Des 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mar 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mar 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mar 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

Populært innen Vitenskap

fastlegen
romkapsel
tingenes-tilstand
rss-nysgjerrige-norge
liberal-halvtime
sinnsyn
forskningno
rekommandert
fjellsportpodden
vett-og-vitenskap-med-gaute-einevoll
rss-paradigmepodden
dekodet-2
rss-rekommandert
nordnorsk-historie
tidlose-historier
jss
rss-lundqvist-podden
rss-overskuddsliv
villmarksliv
rss-zahid-ali-hjelper-deg